Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer Stage IV
Interventions: DRUG: Palbociclib|DRUG: Ribociclib|DRUG: Abemaciclib|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Tamoxifen|DRUG: Fulvestrant|DRUG: Exemestane|DRUG: Alpelisib
Sponsor: Blokhin's Russian Cancer Research Center